Shostak, Kateryna
Chen, Yu
Maurizy, Chloé https://orcid.org/0000-0002-5176-7514
Rademaker, Gilles
Xu, Xinyi
Blomme, Arnaud https://orcid.org/0000-0003-4183-8726
Close, Pierre
Renson, Olivier https://orcid.org/0009-0006-7138-5886
Van Hul, Matthias
Cani, Patrice D https://orcid.org/0000-0003-2040-2448
Klein, Sebastian
Florin, Alexandra
Büttner, Reinhard https://orcid.org/0000-0001-8806-4786
Cataldo, Didier https://orcid.org/0000-0002-3079-7941
Delvenne, Philippe
Nemazanyy, Ivan https://orcid.org/0000-0001-8080-839X
Wathieu, Caroline
Hego, Alexandre
Ormenese, Sandra
Peulen, Olivier https://orcid.org/0000-0002-6933-0134
Thiry, Marc https://orcid.org/0000-0002-4944-584X
Krishnankutty, Roopesh https://orcid.org/0000-0002-1496-6135
Marques, Jair Jr
von Kriegsheim, Alex
Chariot, Alain https://orcid.org/0000-0002-1691-4347
Funding for this research was provided by:
Walloon excellence in life sciences and biotechnology (WELBIO-CR-2019 C - 02 R)
Walloon excellence in life sciences and biotechnology (WELBIO-CR-2022A-02)
Belgian Foundation against Cancer (F/2020/1323)
University of Liege/ARC (ARC UBICOREAR)
Fonds National de la recherche scientifique/EOS (EOS reference number: 40007505)
Fonds National de la recherche scientifique PDR (Convention: FNRS T.0030.21)
Fonds National de la recherche scientifique CDR (Convention: J.0027.22)
University of Louvain ARC (25/30-151)
Article History
Received: 1 April 2025
Revised: 23 February 2026
Accepted: 9 March 2026
First Online: 30 March 2026
Disclosure and competing interests statement
: PDC is inventor on patent applications dealing with the use of specific bacteria and components in the treatment of different diseases. PDC was co-founder of Enterosys.